1 August 2024 false No description of principal activity Taxfiler 2024.6 08163278business:PrivateLimitedCompanyLtd2024-08-012025-07-31 081632782024-07-31 081632782024-08-012025-07-31 08163278business:AuditExempt-NoAccountantsReport2024-08-012025-07-31 08163278business:AbridgedAccounts2024-08-012025-07-31 081632782025-07-31 08163278business:Director12024-08-012025-07-31 08163278business:RegisteredOffice2024-08-012025-07-31 081632782024-07-31 08163278core:WithinOneYear2025-07-31 08163278core:WithinOneYear2024-07-31 08163278core:AfterOneYear2025-07-31 08163278core:AfterOneYear2024-07-31 08163278core:ShareCapitalcore:PreviouslyStatedAmount2025-07-31 08163278core:ShareCapitalcore:PreviouslyStatedAmount2024-07-31 08163278core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-07-31 08163278core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-07-31 08163278core:PreviouslyStatedAmount2025-07-31 08163278core:PreviouslyStatedAmount2024-07-31 08163278business:SmallEntities2024-08-012025-07-31 08163278countries:EnglandWales2024-08-012025-07-31 08163278business:OrdinaryShareClass12024-08-012025-07-31 08163278business:OrdinaryShareClass12023-08-012024-07-31 08163278business:OrdinaryShareClass22024-08-012025-07-31 08163278business:OrdinaryShareClass22023-08-012024-07-31 08163278business:AllOrdinaryShares2024-08-012025-07-31 08163278business:AllOrdinaryShares2023-08-012024-07-31 081632782023-08-012024-07-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 08163278 (England and Wales)
Assay Clinical Research Ltd Unaudited accounts for the year ended 31 July 2025
Assay Clinical Research Ltd Unaudited accounts Contents
Page
- 2 -
Assay Clinical Research Ltd Company Information for the year ended 31 July 2025
Director
Sowmya Raju
Company Number
08163278 (England and Wales)
Registered Office
Highland House 165-167 The Broadway Wimbledon London London SW19 1NE England
- 3 -
Assay Clinical Research Ltd Statement of financial position as at 31 July 2025
2025 
2024 
Notes
£ 
£ 
Fixed assets
Tangible assets
260 
346 
Current assets
Debtors
73,837 
29,901 
Cash at bank and in hand
(22,587)
7,996 
51,250 
37,897 
Creditors: amounts falling due within one year
(64,792)
(3,162)
Net current (liabilities)/assets
(13,542)
34,735 
Total assets less current liabilities
(13,282)
35,081 
Creditors: amounts falling due after more than one year
(179,457)
(142,593)
Net liabilities
(192,739)
(107,512)
Capital and reserves
Called up share capital
200 
200 
Profit and loss account
(192,939)
(107,712)
Shareholders' funds
(192,739)
(107,512)
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the year in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 23 June 2026 and were signed on its behalf by
Sowmya Raju Director Company Registration No. 08163278
- 4 -
Assay Clinical Research Ltd Notes to the Accounts for the year ended 31 July 2025
1
Statutory information
Assay Clinical Research Ltd is a private company, limited by shares, registered in England and Wales, registration number 08163278. The registered office is Highland House, 165-167 The Broadway, Wimbledon, London, London, SW19 1NE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
4
Tangible fixed assets
Total 
£ 
Cost or valuation
At 1 August 2024
1,752 
At 31 July 2025
1,752 
Depreciation
At 1 August 2024
1,406 
Charge for the year
86 
At 31 July 2025
1,492 
Net book value
At 31 July 2025
260 
At 31 July 2024
346 
5
Share capital
2025 
2024 
£ 
£ 
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100 
100 
100 B Ordinary Shares of £1 each
100 
100 
200 
200 
6
Average number of employees
During the year the average number of employees was 3 (2024: 3).
- 5 -